Kedudukan dalam Saham
#35102
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Harga Saham
$1.96
Disegerakkan terakhir: 2022-09-20
Perubahan (1 tahun)
0.00%
Perdagangan Imunon, Inc. (CLSN)
Harga CLSN dengan permodalan pasaran b
Modal pasaran bagi Imunon, Inc.(CLSN)
Modal Pasaran: $4.46M
Sehingga August 2026, Imunon, Inc. mempunyai modal pasaran sebanyak $4.46M. Ini menjadikan Imunon, Inc. syarikat ke-35102nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Imunon, Inc. dari 2008 hingga 2026
CLSN berbanding dengan 5 teratas yang paling popular stocks
| Harga CLSN |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+122,315,667.42%
|
|
|
|
|
$4.490T
|
+100,736,067.78%
|
|
|
|
|
$4.162T
|
+93,385,879.57%
|
|
|
|
|
$3.676T
|
+82,480,743.03%
|
|
|
|
|
$2.833T
|
+63,560,829.91%
|
